Nick Wlazlo revealed that Complement C3 (C3) were longitudinally associated with insulin resistance in type 2 diabetes over a 7-year follow-up period, and may reflect progression of metabolic dysregulation [22]. Here, C3 is linked to type 2 diabetes mellitus.